John Patience insider trades: Accelerate Diagnostics (AXDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
34 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | AXDX | ↑ Buy | 200,000 | $1.57 | $314K | By John Patience Living Trust dated 7/23 | Dec 3, 2024 (0d) |
| Nov 5, 2024 | BDSX | ↑ Buy | 75,000 | $1.38 | $104K | By Patience Enterprises LP | Nov 6, 2024 (1d) |
| Nov 21, 2022 | BDSX | ↑ Buy | 1,739,130 | $1.15 | $2.0M | By John Patience Living Trust dated 7/23 | Nov 21, 2022 (0d) |
| Apr 7, 2022 | BDSX | ↑ Buy | 279,329 | $1.79 | $500K | Direct | Apr 11, 2022 (4d) |
| Dec 30, 2021 | BDSX | ↑ Buy | 137,931 | $4.35 | $600K | By Patience Enterprises LP | Jan 4, 2022 (5d) |
| Dec 30, 2021 | BDSX | ↑ Buy | 22,988 | $4.35 | $100K | By Spouse | Jan 4, 2022 (5d) |
| Nov 23, 2021 | BDSX | ↑ Buy | 10,000 | $6.18 | $62K | By Patience Enterprises LP | Nov 24, 2021 (1d) |
| Nov 18, 2021 | BDSX | ↑ Buy | 9,497 | $6.34 | $60K | By Patience Enterprises LP | Nov 22, 2021 (4d) |
| Aug 19, 2021 | BDSX | ↑ Buy | 8,396 | $8.04 | $67K | By Patience Enterprises LP | Aug 23, 2021 (4d) |
| Aug 17, 2021 | BDSX | ↑ Buy | 1,604 | $7.12 | $11K | By Patience Enterprises LP | Aug 19, 2021 (2d) |
| Oct 30, 2020 | BDSX | ↑ Buy | 30,000 | $18.00 | $540K | By Spouse | Nov 3, 2020 (4d) |
| Mar 24, 2020 | AXDX | ↑ Buy | 5,000 | $6.83 | $34K | By John Patience Trust dated 7/23/1993 | Mar 26, 2020 (2d) |
| Nov 8, 2018 | AXDX | ↑ Buy | 10,000 | $14.96 | $150K | By John Patience Defined Benefit Pension | Nov 13, 2018 (5d) |
| May 23, 2018 | SRCL | ↓ Sell | 6,624 | $63.15 | $418K | Direct | May 24, 2018 (1d) |
| Nov 7, 2017 | AXDX | ↑ Buy | 20,000 | $18.75 | $375K | By John Patience Trust dated 7/23/1993 | Nov 9, 2017 (2d) |
| Nov 6, 2017 | AXDX | ↑ Buy | 38,700 | $18.61 | $720K | By John Patience Trust dated 7/23/1993 | Nov 8, 2017 (2d) |
| Jan 9, 2017 | AXDX | ↑ Buy | 39,500 | $19.00 | $751K | By Patience Enterprises LP | Jan 10, 2017 (1d) |
| Jan 9, 2017 | AXDX | ↑ Buy | 13,200 | $19.00 | $251K | By John Patience Trust dated 7/23/1993 | Jan 10, 2017 (1d) |
| Feb 9, 2016 | AXDX | ↑ Buy | 50,000 | $11.39 | $570K | By John Patience Trust dated 7/23/1993 | Feb 9, 2016 (0d) |
| Dec 15, 2015 | AXDX | ↑ Buy | 29,411 | $17.00 | $500K | By John Patience Defined Benefit Pension | Dec 17, 2015 (2d) |
| Mar 17, 2015 | AXDX] | ↑ Buy | 2,000 | $20.00 | $40K | Note | Mar 18, 2015 (1d) |
| Dec 10, 2014 | SRCL | ↓ Sell | 65,124 | $130.75 | $8.5M | Direct | Dec 11, 2014 (1d) |
| Oct 28, 2013 | AXDX] | ↑ Buy | 7,191 | $12.66 | $91K | Indirect | Oct 29, 2013 (1d) |
| Jun 7, 2013 | SRCL | ↓ Sell | 45,500 | $108.20 | $4.9M | Direct | Jun 10, 2013 (3d) |
| Nov 27, 2012 | SRCL | ↓ Sell | 20,348 | $92.87 | $1.9M | Direct | Nov 28, 2012 (1d) |
| Jun 26, 2012 | AXK | ↑ Buy | 14,000,000 | $1.03 | $14.4M | Through Abeja Ventures, LLC | Jul 3, 2012 (7d) |
| Mar 16, 2012 | SRCL | ↓ Sell | 4,722 | $86.50 | $408K | Direct | Mar 19, 2012 (3d) |
| Mar 15, 2012 | SRCL | ↓ Sell | 52,278 | $87.33 | $4.6M | Direct | Mar 15, 2012 (0d) |
| Jan 14, 2009 | SRCL | ↑ Buy | 1,000 | $46.27 | $46K | by Spouse | Jan 15, 2009 (1d) |
| Jul 9, 2008 | SRCL | ↑ Buy | 39,458 | $50.40 | $2.0M | Direct | Jul 11, 2008 (2d) |
| Jul 8, 2008 | SRCL | ↑ Buy | 29,905 | $49.94 | $1.5M | Direct | Jul 10, 2008 (2d) |
| Jul 7, 2008 | SRCL | ↑ Buy | 100,000 | $50.00 | $5.0M | Direct | Jul 9, 2008 (2d) |
| Jun 1, 2005 | SRCL | ↓ Sell | 12,700 | $50.65 | $643K | Direct | Jun 2, 2005 (1d) |
| May 27, 2005 | SRCL | ↓ Sell | 37,300 | $49.08 | $1.8M | Direct | May 31, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Patience's insider trades
John Patience is a director at Accelerate Diagnostics (AXDX). Since May 27, 2005, John has reported 26 open-market purchases worth $30.8M and 8 sales worth $23.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (50 filings), option exercises (24 filings), other transactions (7 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.